TOKYO -- Japanese drugmaker Shionogi will begin a Phase 3 clinical trial on its COVID-19 vaccine this month, mainly in Vietnam and other Asian countries, CEO Isao Teshirogi said Monday.
COVID vaccines
Shionogi set to begin COVID vaccine Phase 3 trial in Vietnam
Japanese drugmaker aims to make vaccine available domestically early next year
Shionogi CEO Isao Teshirogi said a clinical trial aims to put its "recombinant protein vaccine" on the list of the World Health Organization-approved vaccines. (Source photos by Atsushi Ooka and Jiji)
Read Next
Latest on COVID vaccines
